SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-093977
Filing Date
2024-08-08
Accepted
2024-08-08 16:13:11
Documents
63
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q crnx-20240630.htm   iXBRL 10-Q 1942752
2 EX-31.1 crnx-ex31_1.htm EX-31.1 25927
3 EX-31.2 crnx-ex31_2.htm EX-31.2 25884
4 EX-32.1 crnx-ex32_1.htm EX-32.1 9388
  Complete submission text file 0000950170-24-093977.txt   8527622

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT crnx-20240630.xsd EX-101.SCH 1185286
65 EXTRACTED XBRL INSTANCE DOCUMENT crnx-20240630_htm.xml XML 1636858
Mailing Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121
Business Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121 858-450-6464
Crinetics Pharmaceuticals, Inc. (Filer) CIK: 0001658247 (see all company filings)

IRS No.: 263744114 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38583 | Film No.: 241188468
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)